Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI001549-05
Application #
6532599
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Sizemore, Christine F
Project Start
1998-09-30
Project End
2003-10-31
Budget Start
2002-09-01
Budget End
2003-10-31
Support Year
5
Fiscal Year
2002
Total Cost
$116,370
Indirect Cost

  Institution

Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143

  Publications

Jasmer, Robert M; Snyder, David C; Saukkonen, Jussi J et al. (2004) Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial. Clin Infect Dis 38:363-9
Jasmer, Robert M; Seaman, Christopher B; Gonzalez, Leah C et al. (2004) Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 170:561-6
Jasmer, Robert M; Nahid, Payam; Hopewell, Philip C (2002) Clinical practice. Latent tuberculosis infection. N Engl J Med 347:1860-6
Jasmer, Robert M; Saukkonen, Jussi J; Blumberg, Henry M et al. (2002) Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 137:640-7
Jasmer, R M; Snyder, D C; Chin, D P et al. (2000) Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis. Am J Respir Crit Care Med 162:1648-52